Fusafungine: Difference between revisions
No edit summary |
No edit summary |
||
Line 31: | Line 31: | ||
==Overview== | ==Overview== | ||
'''Fusafungine''' ([[International Nonproprietary Name|INN]]), also known as '''fusafungin''', is an active agent used in [[antibiotic]]s for treatment of | '''Fusafungine''' ([[International Nonproprietary Name|INN]]), also known as '''fusafungin''', is an active agent used in [[antibiotic]]s for treatment of nasal infection|nasal and throat infection. It also possesses [[anti-inflammatory]] properties. It is produced by the [[Ascomycota|ascomycete]] ''Fusarium lateririum'', and marketed by [[Servier]] under the trade name '''Locabiotal''' and Bioparox - in Austria, Germany and Switzerland under the tade name '''Locabiosol'''. | ||
{{Throat preparations}} | {{Throat preparations}} |
Revision as of 19:32, 18 June 2009
Clinical data | |
---|---|
Synonyms | Fusafungin |
ATC code | |
Identifiers | |
CAS Number | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C29H51N2O8 |
Molar mass | 555.73 g·mol−1 |
WikiDoc Resources for Fusafungine |
Articles |
---|
Most recent articles on Fusafungine Most cited articles on Fusafungine |
Media |
Powerpoint slides on Fusafungine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Fusafungine at Clinical Trials.gov Clinical Trials on Fusafungine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Fusafungine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Fusafungine Discussion groups on Fusafungine Patient Handouts on Fusafungine Directions to Hospitals Treating Fusafungine Risk calculators and risk factors for Fusafungine
|
Healthcare Provider Resources |
Causes & Risk Factors for Fusafungine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Fusafungine (INN), also known as fusafungin, is an active agent used in antibiotics for treatment of nasal infection|nasal and throat infection. It also possesses anti-inflammatory properties. It is produced by the ascomycete Fusarium lateririum, and marketed by Servier under the trade name Locabiotal and Bioparox - in Austria, Germany and Switzerland under the tade name Locabiosol.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antibiotics
- Antimicrobial peptides